Koyfin Home > Directory > Health Care > Anika Therapeutics > Cash Flow from Operations

Anika Therapeutics Cash Flow from Operations Chart (ANIK)

Anika Therapeutics annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Anika Therapeutics Cash Flow from Operations for the quarter ending September 09, 2020 was $6m a -122.03% decrease of -7m year over year
  • Anika Therapeutics Cash Flow from Operations for the last 12 months ending September 09, 2020 was $24m a -57.47% decrease of -14m year over year
  • Anika Therapeutics Annual Cash Flow from Operations for 2019 was $37m a 5.64% increase of 2m from 2018
  • Anika Therapeutics Annual Cash Flow from Operations for 2018 was $35m a -16.88% decrease of -6m from 2017
  • Anika Therapeutics Annual Cash Flow from Operations for 2017 was $41m a 40.10% increase of 16m from 2016
Other Cash Flow Metrics:
  • Anika Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $9m a 40.85% increase of 4m year over year
  • Anika Therapeutics Total Revenue for the quarter ending December 12, 2018 was $27m a 21.12% increase of 6m year over year
View Chart On Koyfin

Quarterly ANIK Cash Flow from Operations Data

09/2020$6m
06/2020$4m
03/2020$1m
12/2019$13m
09/2019$10m
06/2019$5m
03/2019$8m
12/2018$10m
09/2018$11m
06/2018$4m

Annual ANIK Cash Flow from Operations Data

2019$37m
2018$35m
2017$41m
2016$24m
2015$40m
2014$40m
2013$25m
2012$11m
2011$10m
2010$8m